Delivery Order SPE2DB22D3501-SPE2DB25FXL54
- Not listed
- This delivery order, awarded on February 3, 2026, represents a $20,047.15 firm fixed-price purchase of Vemlidy 25 mg tablets (30-count unit dose) from AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The contract is funded by the Defense Logistics Agency (DLA), a Department of Defense logistics organization responsible for supplying pharmaceuticals and medical materiel to military healthcare systems. This award was issued on a...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp, the pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, on July 21, 2025, for the supply of Vemlidy 25 mg tablets (30-count units) with a ceiling value of $5,656.80. This is a firm fixed-price delivery order with an ultimate completion date of July 22, 2025, issued with no set-aside designation, indicating the award was competitively awarded. The place of performance is...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency (DLA) on October 31, 2025, for Vemlidy 25 mg tablets in a package quantity of 30 units. This competitive, non-set-aside contract carries a ceiling value of $1,198.50 and is structured as a firm fixed-price delivery order, with an ultimate completion date of November 3, 2025. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a $24.3K delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Vemlidy 25 mg tablets (30-count units). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The contract is expected to be completed by September 8, 2025, and will be performed at the awardee's corporate office location in Conshohocken, PA....
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Vemlidy 25 mg tablets in a quantity of 30 units, with a ceiling value of $11,313.60. This firm fixed-price delivery order is scheduled for completion by September 23, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, leveraging AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,980.71 to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on November 3, 2025, with completion targeted for November 4, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor at its corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger indefinite delivery contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Vemlidy 25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $2,703.17 and an ultimate completion date of December 3, 2025. The award was not set-aside and was competitively awarded, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency awarded a $2,511.19 delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Vemlidy 25 mg tablets (30-count units). This is a firm fixed-price delivery order with an ultimate completion date of October 22, 2025, and carries no set-aside designation, indicating it was competitively awarded. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $1,514.15 to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count unit dose packaging) on December 23, 2025, with completion scheduled for December 24, 2025. This non-competitive, firm fixed-price delivery order represents a pharmaceutical procurement supporting federal medical supply requirements. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Vemlidy 25 mg tablets (30-count units) under a firm fixed-price contract valued at $12,049.24. This is a non-set-aside competitive award with an ultimate completion date of September 19, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FXL54Delivery Order
This delivery order, awarded on September 22, 2025, represents a $3,627.02 firm fixed-price purchase of Vemlidy 25 mg tablets (30-count units) from AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The contract was funded by the Defense Logistics Agency (DLA), the Department of Defense's combat support agency responsible for supplying medical and pharmaceutical products to military and veteran healthcare systems. This award carries no set-aside designation, indicating it was competitively awarded through open competition. The place of performance is listed as Conshohocken, Pennsylvania, and the delivery order is scheduled for completion by September 23, 2025. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.9 million through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. AmerisourceBergen Drug Corp's federal contract portfolio demonstrates significant capability in meeting DoD medical procurement requirements across diverse therapeutic domains and transaction sizes, serving critical healthcare needs for the Defense Health Agency and other military medical systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 9/22/25 |